Abstract Surprisingly few medicines are available to prevent or manage pre-eclampsia, all of which are repurposed from non-pregnant populations and conditions. Analyses of clinical research and development pipelines for pre-eclampsia medicines have identified high-potential candidates; however, the preclinical pipeline has not been interrogated.
Andrew Tuttle
As seen in:
Nature,
Wiley Online Library,
Bandcamp Daily,
PLOS,
Pitchfork,
AARP The Magazine,
AARP,
The Lancet,
loveEXPLORING,
Bryan Times
and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Andrew
Contact Andrew, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack